40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
152.75%
Some net income increase while CRK is negative at -686.89%. John Neff would see a short-term edge over the struggling competitor.
-20.00%
Negative yoy D&A while CRK is 259.00%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
116.70%
Some yoy growth while CRK is negative at -1239.73%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
82.76%
SBC growth while CRK is negative at -7.31%. John Neff would see competitor possibly controlling share issuance more tightly.
36.17%
Slight usage while CRK is negative at -448.21%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
247.37%
AR growth well above CRK's 94.19%. Michael Burry would fear inflated sales or less stringent credit controls vs. competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
36.17%
Some yoy usage while CRK is negative at -332.70%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
34.78%
Lower 'other non-cash' growth vs. CRK's 171.95%, indicating steadier reported figures. David Dodd would confirm no missed necessary write-downs or gains.
124.10%
Some CFO growth while CRK is negative at -14150.91%. John Neff would note a short-term liquidity lead over the competitor.
4.65%
Lower CapEx growth vs. CRK's 61.54%, potentially boosting near-term free cash. David Dodd would confirm no missed expansions that competitor might exploit.
104100.00%
Acquisition growth of 104100.00% while CRK is zero at 0.00%. Bruce Berkowitz sees a mild outflow that must deliver synergy to justify the difference.
91.07%
Purchases growth of 91.07% while CRK is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
-4.65%
We reduce yoy sales while CRK is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
4.65%
We have some outflow growth while CRK is negative at -100.00%. John Neff sees competitor possibly pulling back more aggressively from minor expansions or intangible invests.
405.15%
Investing outflow well above CRK's 59.01%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
-457.20%
We cut debt repayment yoy while CRK is 99.74%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.